Mandate

Vinge advises Lassie AB in its SEK 115 million financing round

May 24, 2022

Vinge has advised the pet insurance company Lassie AB in connection with a SEK 115 million financing round for the purpose of expanding the business internationally and developing the company’s app.

Lassie AB, whose business model incentivises the users to reduce their insurance costs by gaining points through preventive veterinary care, was founded by Hedda Båverud Olsson, Johan Jönsson and Sophie Wilkinson and the company has grown rapidly since its first financing round less than a year ago.

The financing round was led by the British venture capital firm, Felix Capital, and involved several current investors, among others, the institutional investors Inventure and Passion Capital as well as H&M’s chairman of the board, Karl-Johan Person, and Voi’s founder and head of marketing, Fredrik and Caroline Hjelm.

Vinge’s team consisted of Filip Öhrner, Maria Dahlin Kolvik and Viktor Lennartsson.

Related

Vinge advises Revivo Group on the acquisition of Premator

Revivo Group AB has acquired all the shares in Premator AB, the parent company of a group operating in the field of advanced surface treatment with extensive experience in shot blasting, anti-corrosion painting and related services. Operations are conducted in Sweden, Norway and Denmark.
September 03, 2026

Vinge advises the sellers of Berg Propulsion

Vinge has advised the sellers in connection with the sale of Berg Propulsion to Kongsberg Maritime.
September 03, 2026

Vinge advises the sellers on the sale of Nextory to Bonnier Books

Vinge has acted as legal adviser to the sellers in connection with Bonnier Books’ acquisition of Nextory, one of Europe’s leading streaming services for audiobooks and e-books. Bonnier Books is acquiring all shares in Nextory, and the transaction comprises Nextory’s operations in Sweden and internationally. The acquisition is a cash transaction and the parties have agreed not to disclose the purchase price. The transaction is subject to customary regulatory approvals.
September 02, 2026